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Abstract 
About 40% of new compounds have low water solubility, however they are therapeutically active. For such 
drugs, different methods of formulation development should be proposed. Layer by layer assembly has 
recently been studied to solve this problem in which lipophilic drugs have been encapsulated. In this layer 
by layer process, adsorption of different components is done which is facilitated by the electrostatic 
attraction resulting in the formation of multilayer shells of nanometer size. These drug delivery systems 
include nano- and micro-particles and emulsions. In this review article, the formulation methodology, 
advantages, and uses of layer-by-layer assembly approach have been discussed.      
Keywords: Lipophillic drugs, Layer-by-layer microcapsules, Drug delivery 
 
1. Introduction 
There is an increase in the drug formulations containing poor aqueous solubility drugs. Nowadays there are 
about 40% compounds which have poor aqueous solubility, however they are pharmacologically active. 
These molecules face the consequences of low bioavailability in the systemic circulation after oral 
administration, due to which they are not often used. 
After administration of drugs in body, it is absorbed into the systemic circulation from where it is 
transported to various organs. At this point equilibrium is maintained. For the therapeutic effects, the drug 
is then distributed to the target sites. The drug are then metabolized and excreted from the body. Drugs 
sometimes cause adverse effects because they are transported to the site which is not the therapeutic site for 
the drugs. Drug absorption in gastrointestinal tract can be predicted from the drug dissolution.  
A class II and IV drug compound in the Biopharmaceutical Classification System (BCS) is considered to be 
poorly aqueous soluble drug. The absorption of class II drugs is predicted by the dissolution because their 
permeability is good but solubility is less. The BCS class IV drugs have both poor solubility and poor 
permeability and are not good drug candidates. The following systems represent the examples of these 
classes. In 1970’s, for the enhancement of biological activity of compound, phospholipid nucleoside 
conjugates and nucleosides having hydroxyl and amino groups were used. When lipid groups were attached 
to the ara-cytidine or when linked to phospholipids, these formed a pro-drug which was having more 
cytotoxic action compared to ara-cytidine only employed in animal tumor models. 
The new molecules of ara-cytidine showed different pharmacologic profiles like reduced catabolism by 
cytidine deaminase, higher plasma half life, and release of nucleoside monophosphate, this process skip the 
nucleoside phosphorylation which is rate limiting. These new ara-cytidine molecules easily penetrate the 
blood brain barrier and are active to tumor cells [5]. 
Nicotinic acid is a wonder drug for the cure of dyslipdemia which is risk in atherosclerosis. It is also known 
as a wide spectrum lipid drug [6]. It decreases the level of lipoproteins i.e. VLDL and LDL and subcategory 
Lp(a) and also increases the level of  protective HDL lipoproteins. It has been noted that nicotinic acid 
treatment decreases the progression of atherosclerosis, symptoms and death rates from coronary heart 
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disease. Nicotinic acid is now considered to be important in the drug delivery system because it has shown 
to stimulate the ABCA 1 membrane cholesterol transporter [7].  
Phospholipids analogs are active against HIV infection both alone or conjugated with other pharmacologic 
agents [8]. AZT nucleoside analog, when conjugated to the phospholipids, this complex stops viral 
replication by inhibiting viral reverse transcriptase and increasing the production of defective virus particles 
that do not have group120 on the surface of virus which reduced the amount to attach to CD4+ cells and to 
stop the infected cell-cell fusion. The interest is in that data which shows that phospholipids show activity 
against drug resistant variants which is major problem in HIV treatment in world. Due to the development 
of new delivery mechanisms for HIV drugs it has been shown that this approach will reduce side effects 
and fatal effects and hence the transport of drugs to lymphatic systems and CVS and thus preventing 
resistant variants of HIV.  
DDS with new approach has gained much popularity. These are applied to set pharmacokinetic parameters 
(ADME) to enhance the safety and efficacy of drugs. Since we are considering the properties of the 
encapsulated drugs, following properties should be present in the good delivery system [9,10]. 
a. Increase dissolution and solubilization: Poor solubility drugs should be subjected to particle size 
reduction to enhance solubilization during its transport through Gastrointestinal tract 
b. Increasing gastric residence time: By doing so we can increase absorption and dissolution 
c. Increase drug payloads, decrease toxicity, immunogenicity and the stability of drugs in extracellular 
fluids 
d. By regulating transport to lymphatic system can increase the Bioavailability of lipophillic drugs 
e. Targeted delivery of encapsulated drugs reduces side effects and damage to the body. 
f. The span of treatment can be reduced by enhancing Pharmacokinetics or Pharmacodynamic profile 
g. Drug delivery system should be versatile to be able to deliver combination of anti-parasitic agents 
h. Affordable in cost when compared to benefit ratio 
The approaches followed so far does’t elaborates the above requirements.  
Most viable feature of drug delivery systems is controlled release delivery of encapsulated drug at the 
specific site. Different ways are employed to increase the release of encapsulated drug i.e. changes in pH (e. 
g. pH 6.8 in tumor interstitium or 5.0 in endosomes) [11] or the enzyme action in capsule shell [12]. Abrupt 
and immediate release of drug is most wanted but still the release may be slow. So for this purpose change 
in temperature (hyperthermia) [13], light (photodynamic therapy), or mechanical disruption (ultrasound) 
[14,15] are used to open the shell of delivery system. 
The various delivery systems e.g. emulsions, micro emulsions, surfactants, liposome and nanoparticles are 
now mostly considered because these are versatile and have many benefits. Liposomes particles are now 
mostly used delivery system for lipophillic drugs. Liposomes delivery has a pivotal role in drug delivery. 
These formulations are mostly used to decrease toxicity and to enhance targeting into the specific site for 
therapeutic benefits. From this we can assume that liposomes can be used for targeting tissues whether we 
incorporate recognition molecules or not. Gene therapeutic, vaccines, anti-fungals, anti-tumor cells and 
antimicrobials are the classes for which safety and efficacy has been established [16,17].  
Nanoparticles are solid colloidal particles containing various biocompatible polymeric materials, inside 
which a drug is entrapped or attached covalently. For the delivery of nanoparticles biocapsules and 
biodegradable polymers of synthetic nature like poly (D, L-lactic co-glycolate) polyalkylcyanoacrylates are 
used for fabrication of nanoparticles, polysaccarides like curdlan and macromolecules chitosan, albumen 
and gelatin are widely described in literature [18]. Traditional colloidal carrier system e.g. liposomes, 
polymeric nanoparticles and emulsions are advantageous of solid lipid nanoparticles, but here they also 
reduced the draw backs related to it [19]. These nanoparticles have been used with success for the transport 
of various drugs e.g. lipophilic and hydrophilic by different routes. The delivery for lipid based drugs has 
usually single function and do not have diversity (i.e. the incorporation of many drugs in one capsule and 
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for magnetic delivery). Layer-by-layer assembly technology is used for this purpose i.e. fabrication and 
surface modification. 
This method is applied for the stepwise absorption of various compounds (i.e. polyelectrolytes, 
nanoparticles, proteins, enzymes etc) electrostatic attraction helps in the growth of multilayer shells with 
nanometer (thickness) precision [20,21]. The release can be controlled from the enclosed substances if 
layer-by-layer method is applied. In this review mainly the emphasis is on the utility of Layer-by-layer for 
nanoparticles, emulsions and capsule delivery. 
 
2. Preparation of Layer-by-layer systems 
2.1 Standard methods of emulsification 
In order to gain the desired results from the preparation technique special attention should be paid to the 
properties of the container to be used. After the incorporation of drug to the microcontainer the release and 
permeability is vital. While encapsulating lipophillic compounds, repetition of various steps is required in 
which the polarity of the dispersion medium is decreased. These repeated steps are very tiring and time 
consuming and also gives less output that’s why they are not advantageous actually.  
Hence to overcome the disadvantage of the repeated open-close procedure, one step technique on the basis 
of accurate deposition of polyelectrolyte Layer-by-layer has an increase practical value. In this article a new 
procedure for preparing the filled micro and nanocapsules which are an O/W emulsion, in which the 
droplets are coated with Layer-by-layer in the disperse phase. The oil loaded small containers for emulsion 
encapsulation have several benefits; very less work has been done in this regard [22-24], for which results 
were given. 
Many steps are conducted to form Layer-by-layer carriers. Emulsion core by the process of emulsification 
were prepared first in which lipophillic material was dissolved. The process for emulsification is Ultra 
Turrax homogenizer. The change on the core of emulsion is noticed and according to that deposition of 
Layer-by-layer was done with layer of polyelectrolyte. To increase the separation of the disperse droplets 
which have strong electrostatic repulsion, low rpm centrifugation cannot be used as substitute. This is 
because the droplets of disperse phase have high coalescence and deformation. For the purpose of change 
the creamed emulsion layer, is drop-wise added to the polyelectrolyte solution with proper stirring. To 
precede the process of encapsulation further addition of the polyelectrolyte aqueous solution is done. To get 
the desired number of layers charged polyelectrolyte, alternate deposition was carried out. 
As mentioned in the start, the fluid core in this encapsulated emulsion has a role of capsule load. This liquid 
oil is incompressible, deformable and mobile as compared to solid one. Now, on a glass substrate if the 
encapsulated particles of emulsion are transferred there will be interaction of the outer layer of 
polyelectrolyte in the capsule shell and the substrate and these interactions are strong enough to de-shape 
and disrupt the capsule. The capsule destroys after the drying process [25] which in turn releases the oil 
which was loaded in the capsule. Further additions of coats are done until the desired thickness of the shell 
is achieved. Different oils like artificial fats, fish oil, triglycerides, soybean, vitamin B12 or dissolved drugs 
in oil can be used in oil core. Also it depends on the application of the container demand in the various 
fields like medicine, biology, pharmacy or industry of food. 
Previously it was studied that instead of bio-emulsifiers, the biopolymers like proteins can be essentially 
used for the encapsulation of emulsion [22,26,27]. There is an important class of proteins which are meant 
for the encapsulation of Layer-by-layer emulsion. These protein compounds are polyelectrolyte in nature as 
well as the interfacially active because of the lipophilic parts in their structure. At the interface of 
adsorption site these proteins provide a charge and the deposition of the Layer-by-layer occurs by 
conventional polyelectrolytes or biopolyelectrolytes. There is a question about the preparation of primary 
emulsion which is prepared from the water-soluble surfactants whose stability is because of the molecules 
of surfactants on the interface of oil/water and this is related to concentration in bulk. 
About a micrometer scale, multilayer biogenic capsules of proteins were formed while also the lipids on the 
emulsion drops interface [28]. The capsules which are spherical in shape have uniform wall around the 
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fluid interface and the mechanical power is high for that of dry capsule, this was shown by the images taken 
from optical microscopy. If the protein layer is adsorbed the properties will alter at the interface. 
Rhodamine B dye was used to color the capsule shells so as to view the shape, by using florescence 
microscopy. The droplets of chloroform which are present in the aqueous solution having serum albumin of 
human were covered with the co-adsorption of lipids and proteins. As the time passes the chloroform will 
evaporate and the size of the droplets will shrink and a surface with folds will be formed. When the whole 
solvent gets evaporated we will get a capsule which is elastic and hollow from inside.  
Using a single process interfacial polymerization of dopamine for the preparation of monodisperse polymer 
(polydopamine, PDA)  on the emulsion droplets of dimethyl diethoxysilane (DMDES) and after this these 
DMDES were removed with ethanol, this study was done previously [29] if the condensation time for 
emulsion is changed the diameter of PDA can be changed from 400 nm to 2.4 um. If we adjust the 
concentration of the emulsion then we can have a capsule ranging from 10-30 nm. By repeating the 
interfacial polymerization steps we can get a high thickness of dopamine, with three cycles we will have a 
thickness of capsule up to 140 nm. In these emulsion droplets we can load thicoraline like lipophillic and 
stabilized nanoparticles of quantum dots i.e. CdSe/CdS. By means of magnified resolution images of TEM, 
one capsule have quantum dots of 2000 was observed. The PDA capsules which were loaded without 
aggregation were monodispersed.   
Capsosomes having liposomes which are compiled like in cargo were reported to be a new delivery system 
of drugs by Caruso et al. [30]. The characterization of the film of multilayer assembly was carried out for 
poly (allylamine HCI) (PAH), DOPC liposomes (50 nm 1, 2 dioleoyl-sn-glycero-3-phosphocholine) and 
poly electrolytes like PSS (polystyrene sulfonate), this was done by using microbalance of quartz crystal 
along dissipation monitoring, the results were then compared to the growth of the film obtained on silica 
particles of intact liposomes and polyelectrolytes. The film assembly of liposomes on the substrates which 
are planar was then made onto the colloidal spheres of silica and after that the capsosomes were obtained 
when the core of silica was removed. These polyelectrolyte shells of liposome are best as barrier for the 
safeguard of the low molecular weight molecules, fragile compounds and therapeutic agents. Especially it 
is best for the protection of enzymes which easily get denatured in tough conditions and have different 
interactions with the surfaces. The integrity to the structure of liposomes is also provides by the 
polyelctrolyte shells but this depends upon the liposomes (50-200nm) size  
The stable capsosomes were obtained when the silica core was removed, the adsorption on the surface of 
the silica resulted in the rupture of the liposomes, and this was not observed with the multilayers of 
polyelectrolytes. The number of adsorbed liposomes can be increased by incorporating another layer of 
liposomes and also with the high number of polyelectrolyte layers in liposomes layers. This is the diverse 
function of capsosomes that it gathers the benefits of both polyelectrolyte shells and liposomes, and it has 
applications in the formation of organelles and artificial cells in a closed atmosphere. 
2.2 Ultrasonic emulsification 
The way the sonochemical effects occur can be best studied by acoustic cavitation that is the formation of 
bubbles and its increase in size and its rupturing [31]. High energy regions are generated by means of these 
cavitations which have capability of forming pressure and heating in very short time. About 5000 K heat 
has been recorded inside the cavitating microbubble; this was confirmed by the metal carbonyl substitution 
and spectra of sonoluminescence [32]. The rate at which these were cooled was 1010 K/s and the pressure 
was 1000 atm. To keep the temperature low at the surface of the solution in bulk the cavitation process can 
help in this by forming intense conditions of physical an chemical processes at the interface of gas/liquid.  
These intense conditions by cavitation process of microbubble can be used for various transformations of 
physical and chemical nature, this leads to the making of spherical shells which have in its inside cavity 
either liquid or gas. This shows a different microbubble having physical and chemical properties at the 
surface.  The protein shelled non-aqueous microcapsules with liquid filled and microbubbles with air can 
be formed by subjecting serum albumin from human, bovine and hemoglobin solution of proteins to an 
ultrasound of increased intensity i.e. 20KHz for 3minutes [34]. These microspheres are smaller in size than 
the size of erythrocytes i.e. about 2.5 in diameter and can be kept for months and also easily pass through 
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the systemic system. These are formed by two processes like cavitation and emulsification.  The 
microbubbles of albumin can be used experimentally and it shows that they are cross-linked with disulphide 
of cysteine which is present in the center of molecules of proteins. Oxygen and water generates superoxide 
in the acoustic cavitation process which acts as an oxidizing agent in cross-linking. Due to this the proteins 
in the microsphere shell do not denatured prominently and the hemoglobin will retain the heme part in it. 
The thickness of the cross-linked microsphere shell is approximately 6 protein molecules. While 
performing irradiation there is a dependency of microsphere yield on the solutions temperature. While we 
are configuring any experiment we should first optimize the temperature for that. In order to measure the 
concentration of oxygen in biological system the microspheres made from serum albumin of bovine filled 
with nitrogen are used [35].  The size for microsphere is usually 3um and oxygen easily permeates 
through the protein shell. The response of resonance signal of electron paramagnetic to oxygen increases 
about 40 fold after its encapsulation of nitroxides into microsphere, this also safeguard the nitroxide from 
bio-reduction. When the microspheres were injected into mouse, and it was observed after 70 min there was 
no significant reduction in the signal of paramagnetic electron resonance. 
To target the tissues or any specific organ and to enhance the stability, we can change the properties of the 
ultrasonic microspheres. By using layer-by-layer process for the surface modification of microspheres these 
change characteristics can be obtained. The polyglutamate/polyethyleneimine (PEI)/polyacrylic acid (PAA) 
and hydrophobic loaded nano-containers silver dye/polyglutamate/PEI/PAA and 
5,10,15,20-tetraphenylporphin in toluene were obtained both by the process of layer-by-layer and by 
ultrasonic method, which gives stable, about 600nm uniform microspheres [36].  A large forms of drugs 
which are insoluble in water are inside the lipophillic core which is in the container while the permeability 
is taken over by the shells of polyelectrolyte, these have multi-functions and are utilized for the addressing 
of  drugs that are water insoluble, example is the targeting of  anti-tumor drugs. 
With the pH values of 4, 6 and 7 and with the addition of hydrochloric acid dilute, the 5% (w/v) aqueous 
solution of glutamate was layered by the toluene solution 5% (w/v). At the interface of organic and water an 
increased intensity horn of ultrasonic was placed. By the 150W power at the frequency of 20 kHz the 
mixture was sonicated at standard contidions for 3 minutes. In the aqueous phase the remaining 
polyglutamate containers loaded with toluene were suspended. When the polyglutamate shells loaded with 
toluene are formed the polyethyleneimine/polyacrylic acids which are biocompatible shell was performed 
immediately on Layer-by-layer assembly. Alternating layers of PEI/PAA/silver were used to form shells of 
nanostructured Layer-by-layer. The nanocontainers of original polyglutamate which are not coated with 
polyelectrolyte are less stable than the composite nanocontainers. These can be maintained for a month at 
about 2-5°C, as compared to this the nanocontainers of polyglutamate which are fresh are stable at 2-5°C 
for many hours. When polyelectrolytes with opposite charged were used while Layer-by-layer deposition, 
no agglomeration was observed.   
By changing the ionic strength and pH value we can bring variation in the shells of 
polyelectrolyte/polyglutamate which will ultimately release the lipophillic material loaded in the shells. The 
container of Polyglutamate gives a high yield if the values of pH are changed. When the pH is stabled at 6 
or 7 the containers are formed while the treatment with sonochemical will not yield containers at 4.0 pH. 
The polydispersity and the capacity of the container can be increased if the values of the pH are decreased 
from 7 to 6. A drug carrier with a bio-friendly nature was prepared by using a hydrophobic drug i.e. 
rifampicin and vegetable oil, this was studied by Teng et al [37]. The antibiotic, rifampicin is a type of 
rifamycin and is semisynthetic in nature, it is indicated in the treatment of viral and bacterial infections 
because it the RNA synthesis is disrupted by it. Besides the active drug and oil in the core of the carrier, an 
emulsifier is also used that is lecithin. The multilayers of polyethyleneimine/polyglutamate/polyacrylic acid 
were used to make the containers shell, and the lipophillic drug can be released from this shell by changing 
its permeability by means of changes in the pH values of the medium. About 0.15 is the index of 
polydispersity of the containers loaded with polyglutamate oil and for about 4 months at 4°C they used to 
be stable. 
In order to improve the treatments for therapeutic purposes, platforms of nanomedicine of multifunctional 
nature can be developed by combining the various functional materials. An approach of nanomedicine for 
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the formulation of many active agents in one form and for the targeting a specific location, for the ease of 
administration and for the protection of drugs Han et al. [38] gave a combination which comprises of 
protein containers and magnetic nanoparticles. For this purpose the layer by layer process was used and on 
the protein surface the magnetic nanoparticles were coated. The magnetic containers used to flocculate so, 
to stop this we should add polyelectrolyte to the outer layer. On the side of the vial a magnet was placed 
which after 30 minutes turned the brown solution transparent, close to the magnet and near from the brown 
precipitates the containers were collected. When the magnet was removed the magnetic containers after 
little agitation were feasibly redispersed in solution. 
The sonication time, process and volume are the acoustic variables of acoustic power which are important 
for subjecting materials in the sonication process and this also provides an input of energy for the size 
determination of microspheres [39]. The size of microspher is inversely proportional to the time of 
sonication. The equilibrium in the suspension is observed after few minutes when the plateau for size is 
reached. When the amplitude power is reduced there we observe that the equilibrium time also increases. 
The acoustic amplitude and the volume reaction are the factors on which the timings of equilibrium mainly 
depend. The bigger and small microspheres are formed due to low and high amplitude respectively. In the 
ultrasonic vessel, the power distribution affects the size of microspheres. The microspheres formed can be 
arranged by their sizes because of the unequal distribution of acoustic power in the vessel, so by this way a 
broader microspheres size distribution can be achieved. 
The ultrasonic field produces fluctuations in pressure to which the microbubbles gas-filled protein shells 
gave response and these are produced ultrasonically. These gas filled microbubbles coated with polymers 
have a responsive mechanism to the ultrasound. During the acoustic cycle an expansion phase occurs and 
due to this expansion the wall of gas/shell breaks down, this expansion is due to acoustic pressure. Gas 
microspheres with protein shell can be used for target delivery which is accelerated by ultrasound. 
By the use of ultrasound of high intensity in aqueous solution we can form microbubbles which are 
functioning and stable. These microbubbles are coated with lysozymes. Cavalieri et al. [40]. If the 
sonication time and the bonds of intramolecular disulphide are controlled then we can control the extent of 
cross-linking present in the molecules of lysozymes. Optimal distribution of size can be achieved if in the 
sonication process the treatment for denaturation is coupled with the range of 2-5 minutes and 30 seconds. 
The antimicrobial activity of microbubbles coated with lysozymes can remain for many months and also 
stay stable. The properties of microbubbles at the surface can be changed by the deposition of 
polyelectrolyte in layer by layer form on the air-core template protein shell as this is the versatile technique 
and is useful for both diagnostic and therapeutic purposes, also these microbubbles can be used for the 
adsorption of various biolabels and potent drugs. The biological activity of encapsulated epigallocatechin 
gallate (EGCG) nanoparticles and also it inhibit the hepatocyte growth factor as effectively as free form of 
EGCG. About 20-70% weight is of loaded polyphenol. The release time for EGCG is more rather than the 
nanoparticles which are non-encapsulated and also they maintain its activity against breast cancer which is 
created by the HGF intracellular signaling. 
2.3 Polyelectrolyte microcapsules 
Water based systems were usually used in layer-by-layer capsules of polyelectrolytes which are dispersed in 
water based solution in which the materials are encapsulated containing aqueous interior. Many examples 
of non-water based material into polyelectrolyte encapsulation can be mentioned based on the technique of 
changing either of the inner solvent or by using immiscible substances like hydrophobic with hydrophililic 
ones. D. May et al. [42] described a unique delivery agent which comprise of three agents having outer 
layer of  lipid and an inner layer of oil and the core consisting of gaseous agent. The oil layer which then 
investigated is composed of soybean oil, corn oil or the triacetin. The total diameter of these three agents is 
0.5-8 µm and so can bear a big payload in comparison to nanomin diameter shells. These oil shells can be 
filled with lipophillic substances like paclitaxil ones. The thickness of oil layer in the active liposheres 
range from 0.3-1.5 um. Some of the components of microcapsules like chitosan and sodium alginate, 
magnetite nanoparticles, and lipid dipalmitoyl-sn-glycero-3-phosphate (monosodium salt) (DPPA), 
(1,2-dipalmitoyl-sn-glycero-3-phosphocholine) (DPPC) or their composite 10% DPPA/90% DPPC are 
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natural polyelectrolytes [43].  The concentration and temperature of the drug affect their power of 
incorporation of substances. At certain temperature like at 60 °C the power of incorporating substances 
reaches to 22.4%. The phase transition of lipid DPPA film was lower and higher than the properties of 
microcapsules which releases drug at 37 °C and 40 °C, respectively. As a result it was shown that lipid film 
base microcapsules are thermo sensitive and so can efficiently prevent the drug from releasing into the 
non-targeted sites. 
The  layer- by -layer adsorption of polyelectrolytes on sacrificial particles [44] can be used for producing 
polyelectrolyte multilayer capsules templates and this can be utilized for production of  different range 
emulsions of predetermined size and surface chemistry. In case of sacrificial particles silica material of 
mesoporous and nonporous nature were used.  The silica core were pierced by the HF and the oil was 
infiltrated through these semi permeable walls and if oil is in excess then it would be removed by PEM, 
uni-disperse  layer-by-layer coated oil droplets can be obtained by this technique. The capsules obtained 
by this procedure would have size range from 3, 8 and 10 µm. The emulsions of the drugs filled with oleic 
acid inside the capsules of PMA were studied in the process of encapsulation [45]. Capsules having 
disulfide linkages are oxidation-reduction sensitive and that were studied in the release of drugs from 
encapsulated doxorubicin. Viability analysis demonstrated that encapsulated emulsions of these polymers 
are effectively engulfed by targeted tumor cells and this engulfment was pronounced with the 0.5 µm drug 
loaded capsules as compared to 1um or non-encapsulated drugs. 
Human erythrocytes were used as base for polyelectrolyte capsule according to which different polymers of 
poly (sodium styrenesulfonate)-poly (allylamine hydrochloride) were made of the same shape and were 
used for a solvent exchange technique by using different non-aqueous solvents like methanol, ethyl alcohol, 
pentanol, hexanol, octanol, octane and decane and then the outer solvent was alternated with the inside one 
[46]. The scanning laser microscopy has shown the encapsulation of organic solvent in the capsules. If the 
solvent is exchanged the multilayer of the polyelectrolyte will be damaged and the interior part of the 
capsule will be collapsed. The sulphate and amino parts of multi-layers will disappear and the result will be 
cross-linking. For the encapsulation of organic solvents, poly (allylamine hydrochloride), melamine 
formaldehyde (MF) and poly (sodium styrene sulfonate) are also used. Several capsules are lost in the 
process of solvent exchange and the one which have less output is noted. Majority of the capsules will float 
on the surface of the capsule and n-octanol, if n-octanol is loaded inside the MF capsules. The deformation 
of capsules shell happens when the centrifugation speed is raised up to 5000 for 10 min. Mechanically 
stable and heavier capsules should be produced to overcome the problems of yield and efficiency [47]. If 
the bilayers of polyelectrolytes are increased, thicker capsules will be formed and there will be prevention 
of deformation. This process is considered to be time consuming. Also the release from the core of the thick 
capsule is difficult. 
For the carrying of organic solvent i.e. toluene in water, a new matrix capsules were shown which gives 
stable dispersion without the use of surfactants [47]. By the use of opposite charged polyelectrolytes the 
matrix capsules can be formed by the method of Layer-by-layer adsorption. This adsorption is done on the 
calcium carbonate and the removal of core is also done. As the surface inside the calcium carbonate is 
rough and forms matrix capsule, so they have increased efficiency of microencapsulation which remains 
stable for several time. The first layer accumulated on particles was the polycation poly (allylamine 
hydrochloride) after that the anionic layer of poly (styrene sulfonate) is used to coat the particles of calcium 
carbonate modified to poly (allylamine hydrochloride). For achieving desired thickness the process is 
repeated again. EDTA can be used to remove the coating of CaCO3, followed by dispersion of these 
capsules in 96% ethanol solution, followed by keeping for 30min incubation period, followed by dispersion 
in the 1:2 mixture of ethanol and toluene and so on gradually reducing the concentration of ethanol at last 
the resulting matrix form are dispersed in pure toluene. 
By the use of cross-linking reagents, different molecular weights and functions of polymers and template 
particles of mesoporous silica a capsule with the thickness of 15-60nm and diameter of 270-400 nm can be 
formed [49]. The macromolecule’s molecular weight and nature will set the thickness of the capsule shell. 
To adsorb the poly (L-glutamic acid) PGA combined with doxorubicin (Dox), the positively charged 
amine-functionalized particles of mesoporous silica was used. Mesoporous shells were used for the 
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encapsulation of polymer drug conjugate (PGA-Dox). These were then cross-linked in the presence of 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride using 2, 2’- diaminodiethyl disulfide 
dihydrochloride (cystamine). Homogenous sized nanocapsules of PGA-Dox were gained after removing 
mesoporous shells. The diameter of the capsule is 370nm and has thick wall i.e. 55-60 nm. The delivery 
system of PGA-Dox capsule is different i.e. they resist deconstruction and stay intact in physiologic pH 
because of the chains present in the PGA-Dox have lysosomal reducing conditions. It also prevents 
degradation by lysosomal hydrolases which occurs due to stimulus from any chemical inside the cells. They 
cause the death of tumor cells by the transport of Dox to LIM 1215, which are tumor cells of human 
colorectum. They also have a quality of targeted delivery.   
According to Layer-by-layer technique the natural polyelectrolytes of sodium alginate and chitosan having 
water dispersed media were used to constitute the hydrophobic photodynamic drug like Hypocrellin B (HB) 
[48], by this method the HB encapsulation is effective, efficiently delivered to the targeted tumor cells. In 
vitro the intracellular HB loaded microcapsules gives possibility of controlled delivery to the MCF-7 tumor 
cells of breast by a very affective biocompatibility under light prohibited conditions while become toxic to 
the cells under light. The transportation of the HB inside the cells is also affected by the presence of ions on 
the outer layer of the cells and positive charges are responsible for transporting the drug inside the cells. 
2.4 Coated drug crystals 
To prolong the release of microparticles of drug formed by the process of microencapsulation is a good 
method. Also to target the drug to specific region, the microparticles can be surfaced with antigens. These 
properties of microparticles result in the low dose of drug, the adverse events can be reduced and the 
concentration of drug will be achieved quickly. The crystal of drugs which have less aqueous solubility can 
be changed to enhance the control release and to target the delivery of drug in dispersed phase by the 
technique of layer by layer which is perfect for this procedure.  
In aqueous solution the release of the drug was controlled by encapsulating gelatin and polyions along with 
the microcrystals of furosemide [50]. Using layer-by-layer technique the gelatin and polyions were 
accumulated step wise on the microcrystals of drug of 5um. About 2-6 bilayers of PSS/gelation were 
adsorbed on the capsule whose thickness vary from 45-115nm and then stepwise the coatings of poly 
(styrenesulfonate) PSS and poly (dimethyldiallyl NH4Cl) PDDA was done. The capsules coated with 2-6 
bilayer reduced the release of furosemide from microcapsules about 50-300 folds which was not seen in 
uncoated furosemide. The release of furosemide was maintained for about 3 hours in the simulated 
physiologic conditions and this was because of the enhancement in the composition and thickness of the 
walls of microcapsules. While coating furosemide microcrystals step 1 includes the addition of PSS which 
is negatively charged, and then a PDDA polycation was coated on it, this coating was repeated 2 times. 
After that 2-6 layers of gelatin/PSS were coated on the microcrystals, the release at different pH values was 
observed in step 3. 
The partial release of drug at pH 1.4 for 2, 4 and 6 layers of gelatin was 0.11, 0.29 and 0.51%, respectively, 
while the release time of 0.71 h was observed for the unchanged microcrystals of drug. Compared to the 
uncoated micro-crystals, time for encapsulated furosemide was 2, 6 and 10 times greater. For 2, 4 and 6 
bilayers of gelatin, the cumulative release were 1, 5, 3 and 5 h, respectively. The release time was not 
prominently increased by the coating of furosemide with the bilayers of 6-10 PDDA/PSS. A three staged 
release was observed. In the initial few seconds there was a quick release which gradually declined linearly 
with time. The total dissolution of drug is achieved when there is an asymptotic condition; this is observed 
in the last stage. A linear region is not obtained for the release of drug in a solution having 1.4 pH. 
Polysaccharides having 10, 20 and 30 multi-layers were used to encapsulate microcrystals of ibuprofen 
having 5-40 µm size [51] to make the ibuprofen crystals coatings with thickness of shells ranging from 
20-60 nm, the negative charged carboxymethylcellulose, sodium alginate and dextran sulphate and positive 
charged chitosan polysaccharides were used. Before the alteration of crystal surface the coating to the 
crystal was applied directly. By the use of micro-electrophoresis and dispersability measurement the extent 
of first layer was studied. The dispersability of microcapsules of ibuprofen in aqueous solution was greater. 
The thickness of the microcapsule shell reduces the release of ibuprofen but in the dispersion solution, 
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when solubility is increased the release also increases. At pH 7.4, fast release less than one minute is 
observed for drugs which have increased solubility. At pH 1.4, release of drug is very less taking several 
hours showing less solubility of the encapsulated drug. The microcapsules crystals of small, medium and 
large size shows complete release at 20, 30 and 60 sec, respectively at pH 7.4 and the release is about 1, 2  
and 4 h at pH 1.4. The larger the crystals size increased will be the time for release of drug from 
microcapsules. As the ratio of surface to volume is less due to which the release is slower in large crystals. 
If smaller crystals for same extent of ibuprofen are formed it will have increased dissolution in bulk solvent 
as the surface area will be high. A novel approach for the formulation very less aqueous solubility 
components was shown for curcumin [52]. The organic solvent which is miscible with ethanol was used for 
the dissolution of drug. Further, if the aqueous polyelectrolyte was added to the solution then by the process 
of ultrasonication drug nucleation can be induced. Depending upon the power of sonication, initial solvent 
used and the concentration of components the size of the curcumin crystals i.e. 60-100 nm was gained. If 
the adsorption of polycations is done on the particles and then the formation of layer-by-layer nano-shell 
polyelectrolyte, the aggregation between the nanoparticles can be avoided. About 10-20 hours sustained 
release of drugs can be achieved from Layer-by-layer polyelectrolyte encapsulation. In 60% of 
water/ethanol solution the powder of curcumin was dissolved. The addition of protomine which is 
biodegradable or the aqueous poly (allylamine hydrochloride) polycation was then done. Water was slowly 
added during sonication in the solution. This results in the crystal nucleation of curcumin. In the initial 
stage of ultrasonication the growth of the drug particle was stopped. When the sonication was ceased the 
aggregation did not occurred and the particles of crystal were stable. The size of the crystal was affected by 
two factors, one is the addition of water and the other is the concentration of curcumin. At the addition rate 
of 0.4 mL of water/min, particle size of 320 nm was gained and at 0.05 mL/min rate the particles obtained 
were of the size120 nm. The large nanoparticles can also be obtained if the initial concentration of 
curcumin is increased. About 80-90% of the drug can be encapsulated in curcumin nanoparticles because it 
has a thin coating while liposome and micelle have a capacity of 3-5%. 
 
3. Conclusion 
Prominent progress has been made in the past hundred years for the use of layer by layer technology for the 
release and action of lipid based drugs, limited research has been performed in the development of long 
duration delivery medium with shell components which have high compatibility with biological system. 
The latest main disadvantage for the applications are large size of particles which causes release of drug 
(they should have 100-300nm range, and should not be in range of micrometers), there is little 
compatibility of the multilayer component with the biological system (only in some cases biocompatible 
layer-by-layer shell was presented) and the procedure for constructing the delivery particles is very difficult 
and time consuming. To reduce these problems many additional efforts will be required. All the techniques 
discussed in this article have good perspective for further research and study. For further work in this field 
in vivo and in vitro studies should be done on delivery systems. Also development can be done on the 
vehicles which will be Layer-by-layer based, as it is a versatile method and have accuracy of nano-scale for 
various things. 
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